Type e botulinum toxin to treat botulism
AssigneeInnoMed Technologies, Inc.
InventorJohn Joseph
Life of this patent
Estimating the term…
Abstract
Botulism is a potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. There are seven main types of botulinum toxin but the most common is type A (BoNT/A). There are few treatments for botulism which are often limited to supportive efforts. Embodiments include methods of treating botulism using Type E Botulinum toxin (BoNT/E). Intravenous administration allows administration of large doses of BoNT/E to systemically treat the disease and improve recovery times.
Claims20
A method of treating a subject with botulism, the method comprising administering a therapeutic amount of Type E Botulinum toxin.
A method of treating botulism in a patient comprising steps of:
- a) identifying a patient with signs and/or symptoms of botulism,
- b) administering a therapeutic amount of Type E Botulinum toxin to the subject,
- c) monitoring signs and/or symptoms of botulism,
- d) repeating steps b) and c) until the signs and/or symptoms of botulism subside.
Dependencies are inferred from the claim text.